Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Lemborexant PK in Healthy Subjects
NCT02089412Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lemborexant in Insomnia (2 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Last Quantifiable Concentration, Area Under the Concentration-Time Curve From Time Zero to Infinity and 2 more. Started Feb 2014; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02089412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089412.